Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Access icon
Bipolar Disorder

Insights April 15, 2021

Preventing Functional Deterioration in Patients With Bipolar Disorder

Mauricio Tohen, MD, DrPH, MBA ; Joseph F. Goldberg, MD ; Youssef Hassoun, MD ; Suresh Sureddi, MD

J Clin Psychiatry 2020;81(4):OT19046AH1

Dr Joseph Goldberg and others explain why intervening early with effective treatment is critically important for preventing episodes and preserving functioning in patients with bipolar disorder.


Read the full Academic Highlights

Save Save

Share Share

Cite Cite

Related News Articles

AI Predicts Schizophrenia Using Patient Records Ketogenic Diet Shows Promise for Bipolar Disorder Genetics, Income, and Opportunity Shape Socio-Economic Outcomes

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Pharmacokinetics of Olanzapine Intranasal Spray vs Olanzapine IM Suicide and Benzodiazepine Use in Veterans With Bipolar Disorder A New Tool to Refine Lithium Therapy: Simple Formula for a Complex Problem

Related PCC Articles

Oxcarbazepine/Aripiprazole Interaction and Bipolar Relapse A Tale of 2 Lithium Toxicities Insulinoma-Induced Mania

Vol 86 • 2025 • Number 1

Read the Current Issue

Original Research

Psychological Support in Psychedelic Therapy

Original Research

Long-Term Safety and Efficacy of Esmethadone in MDD

Original Research

Suicidal Behaviors and Obstructive Sleep Apnea

Editorial

A Collaborative Endeavor

Brief Report

Sex Differences in PTSD among US Military Veterans

Clinical and Practical Psychopharmacology

Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes in Children and Young Adults

View current Issue

Related Articles

JCP
Complex Polypharmacy in Bipolar Disorder
Insights

Complex Polypharmacy in Bipolar Disorder

June 1, 2021

Which bipolar disorder patients are more likely to receive more than 2 medications, and why? In this video, Dr Goldberg discusses the findings of his recent systematic review focusing...
Joseph F. Goldberg
JCP
Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder
Insights

Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder

April 15, 2021

Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective...
Mauricio Tohen , Joseph F. Goldberg , Youssef Hassoun , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap